For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Heron Therapeutics, Inc.

USPTO Granted Patents = 35

EPO Patents = 8

Trademarks = 36

Forward Citations = 147

Loading Chart...

Loading Chart...

9 inventors (with patents filed for the assignee):

Thomas B Ottoboni (32 out of 53 patents)

Lee Ann Lynn Girotti (14 out of 14 patents)

Han Han (14 out of 19 patents)

4. Lee Ann Lynn Schillinger (4 out of 4 patents)

5. Steven Y Ng (3 out of 21 patents)

6. Jorge Heller (3 out of 56 patents)

7. Hui-Rong Shen (2 out of 6 patents)

8. Joseph Niemann (2 out of 3 patents)

9. Hui Rong Shen (1 out of 4 patents)

10. Barry D Quart (19 patents)

11. Jorge Heller (0 patent)

12. Hui-Rung Shen (0 patent)

35 patents: Sort by Forward Citations

1. 12318376 - Compositions of a polyorthoester and an aprotic solvent (2025-06-03),

2. 12290520 - Methods of use of emulsion formulations of aprepitant (2025-05-06),

3. 12115255 - Methods of use of emulsion formulations of an NK-1 receptor antagonist (2024-10-15),

4. 12115254 - Methods of use of emulsion formulations of an NK-1 receptor antagonist (2024-10-15),

5. 11878074 - Methods of use of emulsion formulations of an NK-1 receptor antagonist (2024-01-23),

6. 11844837 - Compositions of a polyorthoester and an organic acid excipient (2023-12-19),

7. 11744800 - Methods of use of emulsion formulations of an NK-1 receptor antagonist (2023-09-05),

8. 11413350 - Long-acting polymeric delivery systems (2022-08-16),

9. 11253504 - Compositions of a polyorthoester and an aprotic solvent (2022-02-22),

10. 11173118 - Emulsion formulations of an NK-1 receptor antagonist and uses thereof (2021-11-16),

11. 11083797 - Long-acting polymeric delivery systems (2021-08-10),

12. 11083730 - Long-acting polymeric delivery systems (2021-08-10),

13. 10980886 - Compositions of a polyorthoester and an organic acid excipient (2021-04-20),

14. 10953018 - Emulsion formulations of aprepitant (2021-03-23),

15. 10898575 - Long-acting polymeric delivery systems (2021-01-26),

Heron Therapeutics, Inc. is a pharmaceutical company focused on developing innovative treatments for patients suffering from pain-related conditions. With a commitment to improving the lives of those affected by pain, Heron Therapeutics utilizes its proprietary technologies to develop and commercialize new therapeutic options. The company's portfolio includes products designed to provide pain relief and minimize the side effects associated with traditional pain management. Through rigorous research and development efforts, Heron Therapeutics aims to deliver advanced therapies that address unmet medical needs in the field of pain management.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

35 Patents

#170 in San Diego, CA

#2,244 in California

#9,432 in US

#18,637 in the World

San Diego, CA, United States of America

Heron Therapeutics, Inc.

Forward Citations = 147

9 inventors:

Thomas B Ottoboni (32 out of 53 patents)

Lee Ann Lynn Girotti (14 out of 14 patents)

Han Han (14 out of 19 patents)

4. Lee Ann Lynn Schillinger (4 out of 4 patents)

5. Steven Y Ng (3 out of 21 patents)

Please report any incorrect information to support@idiyas.com

Loading…